#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    ABO haemolytic disease of newborn Bronchiectasis Systemic candida Medulloblastoma recurrent Adenocarcinoma pancreas Chronic lymphocytic leukaemia recurrent Acute graft versus host disease in skin Systemic sclerosis pulmonary Penile squamous cell carcinoma Pituitary-dependent Cushing's syndrome Atypical haemolytic uraemic syndrome Type IIa hyperlipidaemia Immunodeficiency common variable Cold type haemolytic anaemia Salivary gland cancer More trials…

    Learn about Rare Diseases

    Angiosarcoma non-metastatic – Trials in Disease Chondrosarcoma metastatic – Life with Disease Mucopolysaccharidosis II – Trials in Disease Nephrotic syndrome Advanced systemic mastocytosis – Trials in Disease Alexander disease – Basic Information Prolymphocytic leukaemia – Diagnostics Angiosarcoma recurrent Medulloblastoma – Life with Disease Tuberous sclerosis complex – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Enfortumab Vedotin Levobupivacaine Istem-01 Cl-Ad-Msc-002 BUDOPRUTUG Maridebart Cafraglutide Gadoxetic Acid, Disodium Clobetasol Propionate Regn7075 Charcoal, Activated Palonosetron Guanfacine Idarubicin Ergocalciferol OXYBUTYNIN HYDROCHLORIDE Apalutamide EGANELISIB Samuraciclib Elranatamab Clavulanic Acid More therapies…

    Learn about Your Condition

    Giant cell arteritis Colon cancer stage II HER2 positive gastric cancer Haemophilia Anaemia of pregnancy Tonsillitis Oral herpes Drug eruption Anaemia of chronic disease Haemodynamic instability Biliary tract disorder Head and neck cancer stage III Noninfective chorioretinitis Cervix carcinoma stage IV Cutibacterium acnes infection More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Warm autoimmune haemolytic anaemia

  • Study of cc-97540 CD19‑Targeted NEX‑T CAR T in participants with chronic immune thrombocytopenia and autoimmune hemolytic anemia

    Not yet recruiting

    2 1 1
    Investigated Drugs:
    • CC-97540
    Denmark Germany

  • Study of ianalumab for adults with primary immune thrombocytopenia or warm-antibody autoimmune hemolytic anemia who previously responded to ianalumab

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Warm autoimmune haemolytic anaemia
    • Immune thrombocytopenia
    Investigated Drugs:
    • Entecavir
    • Ianalumab
    • Danazol
    Belgium Bulgaria Czechia France Germany Hungary +3

  • Study on Povetacicept for Patients with Autoimmune Cytopenias (wAIHA, CAD, ITP)

    Not recruiting

    2 1 1
    Investigated Drugs:
    • Povetacicept
    Austria Germany Italy Norway Spain

  • Study of ianalumab versus placebo in adults with warm autoimmune hemolytic anemia who failed previous treatment

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Entecavir
    • Ianalumab
    • H2-Receptor Antagonists
    France Germany Hungary Italy Romania Spain

  • Study of Obexelimab for Patients with Warm Autoimmune Hemolytic Anemia

    Not recruiting

    3 1
    Investigated Diseases:
    • Warm autoimmune haemolytic anaemia
    Investigated Drugs:
    • Obexelimab
    Italy Poland Spain

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!